ARS-2

· ARS Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARS-2, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria [Phase 2]